Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.

Bazarbachi A, Boumendil A, Finel H, Castagna L, Dominietto A, Blaise D, Diez-Martin JL, Tischer J, Gülbas Z, Wallet HL, Corral LL, Mohty M, Koc Y, Yakoub-Agha I, Schmid C, El Cheikh J, Arat M, Forcade E, Dreger P, Rocha V, García GG, Chalandon Y, Ferra C, Orvain C, Robinson S, Montoto S, Sureda A.

Br J Haematol. 2019 Sep 9. doi: 10.1111/bjh.16182. [Epub ahead of print]

PMID:
31498883
2.

[Treatment of ITP and AIHA in CVID: A systematic literature review].

Lacombe V, Lozac'h P, Orvain C, Lavigne C, Miot C, Pellier I, Urbanski G.

Rev Med Interne. 2019 Aug;40(8):491-500. doi: 10.1016/j.revmed.2019.02.006. Epub 2019 May 14. French.

PMID:
31101329
3.

Next generation sequencing redefines a triple negative essential thrombocythaemia as double-positive with rare mutations on JAK2 V617 and MPL W515 hotspots.

Beucher A, Dib M, Orvain C, Bouvier A, Jouanneau-Courville R, Dobo I, Cottin L, Guardiola P, Rousselet MC, Blanchet O, Hunault M, Ugo V, Luque Paz D.

Br J Haematol. 2019 Sep;186(5):785-788. doi: 10.1111/bjh.15954. Epub 2019 May 14. No abstract available.

PMID:
31087331
4.

Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party.

Bazarbachi A, Labopin M, Battipaglia G, Djabali A, Passweg J, Socié G, Forcade E, Blaise D, Chevallier P, Orvain C, Cornelissen JJ, Arcese W, Chantepie S, Hashaishi K, Cheikh JE, Medinger M, Esteve J, Nagler A, Mohty M.

Haematologica. 2019 Sep;104(9):e398-e401. doi: 10.3324/haematol.2018.211615. Epub 2019 Feb 21. No abstract available.

5.

WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis.

Cottin L, Riou J, Boyer F, Bouvier A, Zannetti A, Blouet A, Truchan-Graczyk M, Jouanneau-Courville R, Beucher A, Ribourtout B, Orvain C, Hunault-Berger M, Blanchet O, Ugo V, Luque Paz D.

Blood Cells Mol Dis. 2019 Mar;75:35-40. doi: 10.1016/j.bcmd.2018.12.004. Epub 2018 Dec 20.

PMID:
30612065
6.

Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC.

Le Bourgeois A, Labopin M, Leclerc M, de Latour RP, Bourhis JH, Ceballos P, Orvain C, Wallet HL, Bilger K, Blaise D, Rubio MT, Guillaume T, Mohty M, Chevallier P; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Oncotarget. 2018 Nov 27;9(93):36603-36612. doi: 10.18632/oncotarget.26391. eCollection 2018 Nov 27.

7.

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC.

Malard F, Labopin M, Cho C, Blaise D, Papadopoulos EB, Passweg J, O'Reilly R, Forcade E, Maloy M, Volin L, Castro-Malaspina H, Hicheri Y, Jakubowski AA, Orvain C, Giralt S, Mohty M, Nagler A, Perales MA.

J Hematol Oncol. 2018 Oct 20;11(1):127. doi: 10.1186/s13045-018-0668-3.

8.

Multifunctional Compounds for Activation of the p53-Y220C Mutant in Cancer.

Miller JJ, Orvain C, Jozi S, Clarke RM, Smith JR, Blanchet A, Gaiddon C, Warren JJ, Storr T.

Chemistry. 2018 Dec 3;24(67):17734-17742. doi: 10.1002/chem.201802677. Epub 2018 Nov 9.

PMID:
30230059
9.

A Freeloader? The Highly Eroded Yet Large Genome of the Serratia symbiotica Symbiont of Cinara strobi.

Manzano-Marín A, Coeur d'acier A, Clamens AL, Orvain C, Cruaud C, Barbe V, Jousselin E.

Genome Biol Evol. 2018 Sep 1;10(9):2178-2189. doi: 10.1093/gbe/evy173.

10.

Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma.

Farhi J, Laribi K, Orvain C, Hamel JF, Mercier M, Sutra Del Galy A, Clavert A, Rousselet MC, Tanguy-Schmidt A, Hunault-Berger M, Moles-Moreau MP.

Ann Hematol. 2018 Dec;97(12):2391-2401. doi: 10.1007/s00277-018-3468-5. Epub 2018 Aug 8.

PMID:
30091022
11.

Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.

Bouvier A, Ribourtout B, François S, Orvain C, Paz DL, Beucher A, Guérard A, Guardiola P, Ugo V, Blanchet O, Geneviève F, Schmidt A, Hunault-Berger M.

Eur J Haematol. 2018 Oct;101(4):570-574. doi: 10.1111/ejh.13143. Epub 2018 Sep 3. Review.

PMID:
30007088
12.

Inherited or acquired modifiers of iron status may dramatically affect the phenotype in dehydrated hereditary stomatocytosis.

Orvain C, Da Costa L, Van Wijk R, Pissard S, Picard V, Mansour-Hendili L, Cunat S, Giansily-Blaizot M, Cartron G, Schved JF, Aguilar-Martinez P.

Eur J Haematol. 2018 Oct;101(4):566-569. doi: 10.1111/ejh.13135. Epub 2018 Aug 31.

PMID:
29969830
13.

Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence.

Orvain C, Beloncle F, Hamel JF, Del Galy AS, Thépot S, Mercier M, Kouatchet A, Farhi J, Francois S, Ifrah N, Mercat A, Asfar P, Hunault-Berger M, Tanguy-Schmidt A.

Ann Hematol. 2018 Sep;97(9):1601-1609. doi: 10.1007/s00277-018-3320-y. Epub 2018 May 2.

PMID:
29717367
14.

Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of Action.

Babak MV, Pfaffeneder-Kmen M, Meier-Menches SM, Legina MS, Theiner S, Licona C, Orvain C, Hejl M, Hanif M, Jakupec MA, Keppler BK, Gaiddon C, Hartinger CG.

Inorg Chem. 2018 Mar 5;57(5):2851-2864. doi: 10.1021/acs.inorgchem.7b03210. Epub 2018 Feb 14.

PMID:
29442506
15.

Towards standards for human fecal sample processing in metagenomic studies.

Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, Tramontano M, Driessen M, Hercog R, Jung FE, Kultima JR, Hayward MR, Coelho LP, Allen-Vercoe E, Bertrand L, Blaut M, Brown JRM, Carton T, Cools-Portier S, Daigneault M, Derrien M, Druesne A, de Vos WM, Finlay BB, Flint HJ, Guarner F, Hattori M, Heilig H, Luna RA, van Hylckama Vlieg J, Junick J, Klymiuk I, Langella P, Le Chatelier E, Mai V, Manichanh C, Martin JC, Mery C, Morita H, O'Toole PW, Orvain C, Patil KR, Penders J, Persson S, Pons N, Popova M, Salonen A, Saulnier D, Scott KP, Singh B, Slezak K, Veiga P, Versalovic J, Zhao L, Zoetendal EG, Ehrlich SD, Dore J, Bork P.

Nat Biotechnol. 2017 Nov;35(11):1069-1076. doi: 10.1038/nbt.3960. Epub 2017 Oct 2.

PMID:
28967887
16.

Diagnostic approach to hemoglobins with high oxygen affinity: experience from France and Belgium and review of the literature.

Orvain C, Joly P, Pissard S, Badiou S, Badens C, Bonello-Palot N, Couque N, Gulbis B, Aguilar-Martinez P.

Ann Biol Clin (Paris). 2017 Feb 1;75(1):39-51. doi: 10.1684/abc.2016.1204. Review.

PMID:
28057606
17.

Monomeric Ti(iv)-based complexes incorporating luminescent nitrogen ligands: synthesis, structural characterization, emission spectroscopy and cytotoxic activities.

Khalil G, Orvain C, Fang L, Barloy L, Chaumont A, Gaiddon C, Henry M, Kyritsakas N, Mobian P.

Dalton Trans. 2016 Nov 29;45(47):19072-19085.

PMID:
27858023
18.

Impact of cyclometalated ruthenium(II) complexes on lactate dehydrogenase activity and cytotoxicity in gastric and colon cancer cells.

Rico Bautista H, Saavedra Díaz RO, Shen LQ, Orvain C, Gaiddon C, Le Lagadec R, Ryabov AD.

J Inorg Biochem. 2016 Oct;163:28-38. doi: 10.1016/j.jinorgbio.2016.07.014. Epub 2016 Jul 26.

PMID:
27513948
19.

Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study.

Orvain C, Luque Paz D, Dobo I, Cottin L, Le Calvez G, Chauveau A, Mercier M, Farhi J, Boyer F, Ianotto JC, Guibourg B, Rousselet MC, Zandecki M, Ifrah N, Hunault-Berger M, Ugo V, Genevieve F.

Ann Hematol. 2016 Oct;95(11):1819-23. doi: 10.1007/s00277-016-2784-x. Epub 2016 Sep 1.

PMID:
27582015
20.

Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care.

Orvain C, Beloncle F, Hamel JF, Thépot S, Mercier M, Kouatchet A, Farhi J, Francois S, Guardiola P, Asfar P, Hunault-Berger M, Mercat A, Ifrah N, Tanguy-Schmidt A.

Transplantation. 2017 Feb;101(2):437-444. doi: 10.1097/TP.0000000000001143.

PMID:
26950729
21.

Expression and functional studies of the GDNF family receptor alpha 3 in the pancreas.

Nivlet L, Herrmann J, Martin DE, Meunier A, Orvain C, Gradwohl G.

J Mol Endocrinol. 2016 Feb;56(2):77-90. doi: 10.1530/JME-15-0213. Epub 2015 Nov 17.

22.

Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.

Couturier MA, Huguet F, Chevallier P, Suarez F, Thomas X, Escoffre-Barbe M, Cacheux V, Pignon JM, Bonmati C, Sanhes L, Bories P, Daguindau E, Dorvaux V, Reman O, Frayfer J, Orvain C, Lhéritier V, Ifrah N, Dombret H, Hunault-Berger M, Tanguy-Schmidt A.

Am J Hematol. 2015 Nov;90(11):986-91. doi: 10.1002/ajh.24130. Epub 2015 Oct 8.

23.

Severe viral hepatitis in a patient with chronic lymphocytic leukemia (CLL) complicated with autoimmune hemolytic anemia (AIHA), treated with steroids.

Orvain C, Ducancelle A, Eymerit-Morin C, Rousselet MC, Oberti F, Hunault-Berger M, Tanguy-Schmidt A.

J Clin Virol. 2015 Jan;62:66-8. doi: 10.1016/j.jcv.2014.11.013. Epub 2014 Nov 18. Review.

PMID:
25542474
24.

Comparison of library preparation methods reveals their impact on interpretation of metatranscriptomic data.

Alberti A, Belser C, Engelen S, Bertrand L, Orvain C, Brinas L, Cruaud C, Giraut L, Da Silva C, Firmo C, Aury JM, Wincker P.

BMC Genomics. 2014 Oct 20;15:912. doi: 10.1186/1471-2164-15-912.

25.

Miconazole mucoadhesive buccal tablet in high-dose therapy with autologous stem cell transplantation (HDT/ASCT)-induced mucositis.

Orvain C, Moles-Moreau MP, François S, Mercier M, Moal F, Hamel JF, Parot-Schinkel E, Ifrah N, Hunault-Berger M, Tanguy-Schmidt A.

Support Care Cancer. 2015 Feb;23(2):359-64. doi: 10.1007/s00520-014-2365-2. Epub 2014 Aug 3.

PMID:
25084742
26.

Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.

Orvain C, Augusto JF, Besson V, Marc G, Coppo P, Subra JF, Sayegh J.

Int Urol Nephrol. 2014 Jan;46(1):239-42. doi: 10.1007/s11255-013-0401-7. Epub 2013 Feb 24.

PMID:
23435773
27.

[Transfusion support of haematological malignancies in 2012: evolution of the recommendations].

Marchand T, Orvain C, Farhi J, Boyer F, Schmidt-Tanguy A.

Transfus Clin Biol. 2012 Nov;19(4-5):150-3. doi: 10.1016/j.tracli.2012.07.020. Epub 2012 Oct 4. French. No abstract available.

PMID:
23039957
28.

Rfx6 is an Ngn3-dependent winged helix transcription factor required for pancreatic islet cell development.

Soyer J, Flasse L, Raffelsberger W, Beucher A, Orvain C, Peers B, Ravassard P, Vermot J, Voz ML, Mellitzer G, Gradwohl G.

Development. 2010 Jan;137(2):203-12. doi: 10.1242/dev.041673.

29.

The transcription factor c-Myb affects pre-mRNA splicing.

Orvain C, Matre V, Gabrielsen OS.

Biochem Biophys Res Commun. 2008 Jul 25;372(2):309-13. doi: 10.1016/j.bbrc.2008.05.054. Epub 2008 May 20.

PMID:
18498763
30.

Transcription factors in pancreatic development. Animal models.

Martin M, Hauer V, Messmer M, Orvain C, Gradwohl G.

Endocr Dev. 2007;12:24-32. doi: 10.1159/000109602. Review.

PMID:
17923766
31.

Pancreatic islet progenitor cells in neurogenin 3-yellow fluorescent protein knock-add-on mice.

Mellitzer G, Martín M, Sidhoum-Jenny M, Orvain C, Barths J, Seymour PA, Sander M, Gradwohl G.

Mol Endocrinol. 2004 Nov;18(11):2765-76. Epub 2004 Aug 5.

PMID:
15297605
32.

Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells.

Delva L, Gallais I, Guillouf C, Denis N, Orvain C, Moreau-Gachelin F.

Oncogene. 2004 May 27;23(25):4389-99.

PMID:
15064749
33.

The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.

Matre V, Høvring PI, Fjeldheim AK, Helgeland L, Orvain C, Andersson KB, Gautvik KM, Gabrielsen OS.

Biochem J. 2003 Jun 15;372(Pt 3):851-9.

34.

Identification of an RNA binding specificity for the potential splicing factor TLS.

Lerga A, Hallier M, Delva L, Orvain C, Gallais I, Marie J, Moreau-Gachelin F.

J Biol Chem. 2001 Mar 2;276(9):6807-16. Epub 2000 Nov 29.

35.

PF4 inhibits thrombin-stimulated MMP-1 and MMP-3 metalloproteinase expression in human vascular endothelial cells.

Klein-Soyer C, Duhamel-Clérin E, Ravanat C, Orvain C, Lanza F, Cazenave JP.

C R Acad Sci III. 1997 Nov;320(11):857-68.

PMID:
9499937
36.

Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents.

Céraline J, Deplanque G, Duclos B, Limacher JM, Hajri A, Noel F, Orvain C, Frébourg T, Klein-Soyer C, Bergerat JP.

Int J Cancer. 1998 Jan 30;75(3):432-8.

37.

Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells.

Duhamel-Clérin E, Orvain C, Lanza F, Cazenave JP, Klein-Soyer C.

Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1931-8.

PMID:
9351356
38.

Angiogenesis inhibitor SR 25989 upregulates thrombospondin-1 expression in human vascular endothelial cells and foreskin fibroblasts.

Klein-Soyer C, Céraline J, Orvain C, de la Salle C, Bergerat JP, Cazenave JP.

Biol Cell. 1997 Jul;89(4):295-307.

PMID:
9447704

Supplemental Content

Loading ...
Support Center